KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) EBT Margin (2016 - 2025)

Eli Lilly (LLY) has disclosed EBT Margin for 17 consecutive years, with 42.85% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 562.0% year-over-year to 42.85%, compared with a TTM value of 39.48% through Dec 2025, up 1133.0%, and an annual FY2025 reading of 39.48%, up 1133.0% over the prior year.
  • EBT Margin was 42.85% for Q4 2025 at Eli Lilly, up from 41.09% in the prior quarter.
  • Across five years, EBT Margin topped out at 43.56% in Q2 2025 and bottomed at 4.5% in Q3 2023.
  • Average EBT Margin over 5 years is 26.27%, with a median of 25.71% recorded in 2022.
  • The sharpest move saw EBT Margin crashed -1805bps in 2023, then soared 2721bps in 2025.
  • Year by year, EBT Margin stood at 23.0% in 2021, then increased by 25bps to 28.71% in 2022, then dropped by -7bps to 26.82% in 2023, then surged by 39bps to 37.23% in 2024, then grew by 15bps to 42.85% in 2025.
  • Business Quant data shows EBT Margin for LLY at 42.85% in Q4 2025, 41.09% in Q3 2025, and 43.56% in Q2 2025.